Treatment options for refractory and difficult to treat seizures: focus on vigabatrin

Overview of attention for article published in Therapeutics and Clinical Risk Management, September 2011

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

patent: 8 patents

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 5 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 8 patents that reference this research output.

Methods of treating seizure disorders and Prader-Willi syndrome

Grant US-11918551-B2

United States of America

Use of (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and (S)-3-ami…

Grant US-11771671-B2

United States of America

Use of MIR101 or MIR128 in the treatment of seizure disorders

Grant US-11761006-B2

United States of America

Use of (S)-3-amino-4-(difluoromethylenyl) cyclopent-1-ene-1-carboxylic acid and related…

Grant US-11660277-B2

United States of America

Use of MIR101 or MIR128 in the treatment of seizure disorders

Grant US-10870855-B2

United States of America

Use of (s)-3-amino-4-(difluoromethylenyl) cyclopent-1-ene-l-carboxylic acid and related…

Grant US-10813899-B2

United States of America

Use of (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and (S)-3-ami…

Grant US-10653652-B2

United States of America

Methods of treating seizure disorders

Application US-10265300-B2

United States of America